Global /China /Healthcare /Medical Devices /300030
chevron_leftBack
Improve Medical Instruments Co., Ltd. logo

Improve Medical Instruments Co., Ltd.

300030
SHE: 300030 Delayed
8.32CNY 1.8%
1.23 USD
As of 14 June 2026, Improve Medical Instruments Co., Ltd. has a market cap of $372.8M USD, ranking #17176 globally and #5344 in China. It ranks #1560 in the Healthcare sector, and #328 in the Medical Devices industry.
Global Rank
17176
Country Rank
5344
Sector Rank
1560
Industry Rank
328
Key Stats
Market Cap
$372.8MUSD
2.53B CNY
Enterprise Value
$373.42MUSD
2.53B CNY
Revenue (TTM)
$68.78MUSD
466.04M CNY
EBITDA (TTM)
$11.17MUSD
75.59M CNY
Net Income (TTM)
$4.19MUSD
28.4M CNY
EBITDA Margin
16%
Profit Margin
6.1%
PE Ratio
87.2
PS Ratio
5.4
PB Ratio
3.7
EV/EBITDA
32.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Guanhua Deng open_in_new
Employees
790
Founded
1996
Website
improve-medical.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
1.8% 0.5% 6.1% 1% 2.3% 39%

News

Loading...

Markets

Exchange Ticker Price
Shenzhen Stock Exchange
MIC: XSHE
PRIMARY
300030
阳普医疗科技股份有限公司 Class A
ISIN: CNE100000JL3
Shares Out.:
309.187M1 Shares Float: 280.038M2
TV:
SA:
YF:
GF:
BA:
MS:
8.32 CNY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Improve Medical Instruments Co., Ltd.

Improve Medical Instruments Co., Ltd. engages in the provision of relevant technologies, products, and services for clinical laboratory and clinical nursing in China and internationally. It provides clinical laboratory products comprising urine, feces, and thrombosis viscoelastic analysis systems; and automatic biosafety decappers; and Q-VELOX, an intelligent molecular diagnostic workstation. The company also offers offers specimen processing equipment, including evacuated blood collection systems, evacuated blood collection tubes, multi-sample needles, blood collection sets, tourniquets and disposable tourniquets, urine collection systems, and holders under IMPROVACUTER brand name; and IMPROMINI capillary blood collection systems, IMPROSWAB microbiological transportation systems, IMPRONURSE infusion pumps and syringe pumps, LONGX urine analysis systems, in-vitro diagnostic reagents, IMPROSAFE safety blood collection needles, IMPROSWAB microbiological transport swabs, IMPROVE sharps containers, liquid biopsy pre-analytical systems, etc. In addition, it provides clinical nursing products, including automatic, handheld, pulsewave, and smart wireless blood pressure monitors; and intelligent management solutions, such as blood collection tube preparation systems, friendly graphic user interfaces, intelligent sorters, multi-function blood collection tables, intelligent queue systems, urine collection tube preparation systems, automatic tube packer systems, and consumable labels, as well as CryoMax vials and liquid nitrogen freezing storage boxes. The company was formerly known as Guangzhou Improve Medical Instruments Co., Ltd. and changed its name to Improve Medical Instruments Co., Ltd. in December 2021. The company was founded in 1996 and is headquartered in Guangzhou, China.

Similar Companies

Industry: Medical Devices (China)
Name
Market Cap diff.
PE
$30.06B
203.66B CNY
8K%
26.0
$13.61B
92.23B CNY
4K%
48.5
$5.61B
38.02B CNY
1K%
23.4
$5.52B
37.43B CNY
1K%
52.7
688617
$5.04B
34.14B CNY
1K%
39.6
$4.55B
30.86B CNY
1K%
13.7
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
$173.27B
46K%
25.8
$160.73B
43K%
56.7
$159.07B
43K%
25.6
DHR
$126.55B
34K%
34.7
SYK
$120.69B
32K%
38.3
MDT
$101.9B
27K%
22.2
chevron_leftBack